Company intelligence / Profile preview
Matrixx Initiatives
Phoenix, Arizona, United Stateszicam.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Matrixx Initiatives has commercialized several over-the-counter remedies, most notably Zicam products, with some supportive clinical studies indicating a reduction in duration or severity of cold and allergy symptoms, though some of its products have faced regulatory controversy and warning over safety concerns[2][4].
- Therapeutic areas
- ImmunologyPulmonologyInfectious Diseases
- Modalities
- Small moleculeHomeopathic
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
BioDelivery Technologies (Gel Tech LLC joint venture, historical)
Beyond the preview
Go deeper on Matrixx Initiatives.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matrixx Initiatives.